Health Canada21 Oct 2026
Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.
Health Canada published a recall notice for Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each on 21 Oct 2026. It is one of 326 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 21 Oct 2026
- Recall type
- Health product recall
- Companies
- Lupin Pharma Canada Limited. · 550-1111 rue St-Charles Ouest · Longueuil, QC, J4K 5G4
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each. What you should do What to do: Verify whether your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada. Additional information Previous recalls or alerts Affected products: Brand Product Name Market Authorization Dosage Form Strength Lot Number Lupin Pharma Canada Ltd. Femyso Mifepristone 200 mg / Misoprostol 200 mcg tablet DIN 02560569 Kit, Tablet Mifepristone 200 mg / Misoprostol 200 mcg NR02557A-R Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.